FDA calls on Congress to create new regulations for hemp-derived CBD products
The FDA said Thursday that there are still too many unknowns about the burgeoning market for CBD products to regulate them as either food or supplements.
Pfizer's new trial vaccine for RSV is over 85% effective in older adults
Pfizer announced on Thursday that a vaccine designed to stop respiratory syncytial virus, or RSV, infections is over 85% effective in older adults.
Pfizer enlists children and adults for Lyme disease vaccine in a late stage clinical trial
On Monday, Pfizer and Valneva announced they will enlist 6,000 participants for a late-stage clinical trial of a Lyme disease vaccine.